# A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex

> **NCT00002281** · NA · COMPLETED · sponsor: **Amgen** · enrollment: 24 (—)

## Conditions studied

- HIV Infections
- Cytopenias

## Interventions

- **DRUG:** Filgrastim
- **DRUG:** Epoetin alfa
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00002281
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 24 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002281, "A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00002281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*